よむ、つかう、まなぶ。
11【参考資料１－６】9価HPVワクチンファクトシート (41 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_29181.html |
| 出典情報 | 厚生科学審議会予防接種・ワクチン分科会（第41回 11／18）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
1553
３. 引⽤⽂献
1588
15. 厚⽣労働省.がん予防重点健康教育及びがん検診実施のための指針.（健発第０３３１０
1589
５８号平成２０年３⽉３１⽇厚⽣労働省健康局⻑通知別添）
（平成２８年２⽉４⽇⼀部改正）
1590
https://www.mhlw.go.jp/file/06-Seisakujouhou-10900000-Kenkoukyoku/0000111662.pdf
1555
1. Bzhalava D, Eklund C, Dillner J. (2015). International standardization and classification
1591
16.
1556
of human papillomavirus types. Virology 476:341‒344.
1592
association. Rev Med Virol 25 Suppl 1(Suppl Suppl 1): 2-23.
1557
https://doi.org/10.1016/j.virol.2014.12.028
1593
17. Giuliano, A. R., et al. (2011). Incidence and clearance of genital human papillomavirus
1558
2.
1594
infection in men (HIM): a cohort study. Lancet 377(9769): 932-940.
1554
Muñoz, N., et al. (2003). Epidemiologic classification of human papillomavirus types
Doorbar, J., et al. (2015). Human papillomavirus molecular biology and disease
1559
associated with cervical cancer. N Engl J Med 348(6): 518-527.
1595
18. Backes, D. M., et al. (2009). Systematic review of human papillomavirus prevalence in
1560
3. Muñoz, N., et al. (2004). Against which human papillomavirus types shall we vaccinate
1596
invasive penile cancer. Cancer Causes Control 20(4): 449-457.
1561
and screen? The international perspective. Int J Cancer 111(2): 278-285.
1597
19. Arbyn, M., et al. (2020). Estimates of incidence and mortality of cervical cancer in 2018:
1562
4.
1598
a worldwide analysis. Lancet Glob Health 8(2): e191-e203.
1563
Vaccine 24 Suppl 3: S3/11-25.
1599
https://www.ncbi.nlm.nih.gov/pubmed/31812369
1564
5.
1600
20. Baldur-Felskov, B., et al. (2014). Incidence of cervical lesions in Danish women before
1565
application. Nat Rev Cancer 2(5): 342-350.
1601
and after implementation of a national HPV vaccination program. Cancer Causes Control
1566
6. Bosch, F. X., et al. (2012). Reframing cervical cancer prevention. Expanding the field
1602
25(7): 915-922. https://www.ncbi.nlm.nih.gov/pubmed/24797870
1567
towards prevention of human papillomavirus infections and related diseases. Vaccine 30
1603
21. Gertig, D. M., et al. (2013). Impact of a population-based HPV vaccination program on
1568
Suppl 5: F1-11.
1604
cervical abnormalities: a data linkage study. BMC Med 11: 227.
1569
7. Moscicki, A. B., et al. (2012). Updating the natural history of human papillomavirus and
1605
https://www.ncbi.nlm.nih.gov/pubmed/24148310
1570
anogenital cancers. Vaccine 30 Suppl 5(0 5): F24-33.
1606
22. Kjaer, S. K., et al. (2018). A 12-Year Follow-up on the Long-Term Effectiveness of the
1571
8. Demarco, M., et al. (2020). A study of type-specific HPV natural history and implications
1607
Quadrivalent Human Papillomavirus Vaccine in 4 Nordic Countries. Clin Infect Dis 66(3):
1572
for contemporary cervical cancer screening programs. EClinicalMedicine 22: 100293.
1608
339-345.
1573
9. Castle, P. E., et al. (2006). Human papillomavirus prevalence in women who have and
1609
23. Pollock, K. G., et al. (2014). Reduction of low- and high-grade cervical abnormalities
1574
have not undergone hysterectomies. J Infect Dis 194(12): 1702-1705.
1610
associated with high uptake of the HPV bivalent vaccine in Scotland. Br J Cancer 111(9):
1575
10. Moscicki, A. B., et al. (2004). Regression of low-grade squamous intra-epithelial lesions
1611
1824-1830 https://www.ncbi.nlm.nih.gov/pubmed/25180766
1576
in young women. Lancet 364(9446): 1678-1683.
1612
24.
1577
11. Jacobs, M. V., et al. (2000). Distribution of 37 mucosotropic HPV types in women with
1613
cancers. Int J Cancer 142(10): 2186-2187.
1578
cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types.
1614
https://www.ncbi.nlm.nih.gov/pubmed/29280138
1579
Int J Cancer 87(2): 221-227.
1615
25. Guo, F., et al. (2018). Cervical Cancer Incidence in Young U.S. Females After Human
1580
12. Hildesheim, A., et al. (2007). Effect of human papillomavirus 16/18 L1 viruslike particle
1616
Papillomavirus Vaccine Introduction. Am J Prev Med 55(2): 197-204.
1581
vaccine among young women with preexisting infection: a randomized trial. Jama 298(7):
1617
https://www.ncbi.nlm.nih.gov/pubmed/29859731
1582
743-753.
1618
26. Lei, J., et al. (2020). HPV Vaccination and the Risk of Invasive Cervical Cancer. N Engl
1583
13. Woodman, C. B., et al. (2007). The natural history of cervical HPV infection: unresolved
1619
J Med 383(14): 1340-1348. https://www.ncbi.nlm.nih.gov/pubmed/32997908
1584
issues. Nat Rev Cancer 7(1): 11-22.
1620
27. 国⽴がん研究センター がん情報サービス. がんに関する統計データのダウンロード.
Parkin, D. M. and F. Bray (2006). Chapter 2: The burden of HPV-related cancers.
zur Hausen, H. (2002). Papillomaviruses and cancer: from basic studies to clinical
Luostarinen, T., et al. (2018). Vaccination protects against invasive HPV-associated
1585
14. Matsumoto, K., et al. (2011). Predicting the progression of cervical precursor lesions by
1621
https://ganjoho.jp/reg_stat/statistics/dl/index.html
1586
human papillomavirus genotyping: a prospective cohort study. Int J Cancer 128(12): 2898-
1622
28. Katanoda, K., et al. (2017). Childhood, adolescent and young adult cancer incidence in
1587
2910.
1623
Japan in 2009-2011. Jpn J Clin Oncol 47(8): 762-771.
81
82
３. 引⽤⽂献
1588
15. 厚⽣労働省.がん予防重点健康教育及びがん検診実施のための指針.（健発第０３３１０
1589
５８号平成２０年３⽉３１⽇厚⽣労働省健康局⻑通知別添）
（平成２８年２⽉４⽇⼀部改正）
1590
https://www.mhlw.go.jp/file/06-Seisakujouhou-10900000-Kenkoukyoku/0000111662.pdf
1555
1. Bzhalava D, Eklund C, Dillner J. (2015). International standardization and classification
1591
16.
1556
of human papillomavirus types. Virology 476:341‒344.
1592
association. Rev Med Virol 25 Suppl 1(Suppl Suppl 1): 2-23.
1557
https://doi.org/10.1016/j.virol.2014.12.028
1593
17. Giuliano, A. R., et al. (2011). Incidence and clearance of genital human papillomavirus
1558
2.
1594
infection in men (HIM): a cohort study. Lancet 377(9769): 932-940.
1554
Muñoz, N., et al. (2003). Epidemiologic classification of human papillomavirus types
Doorbar, J., et al. (2015). Human papillomavirus molecular biology and disease
1559
associated with cervical cancer. N Engl J Med 348(6): 518-527.
1595
18. Backes, D. M., et al. (2009). Systematic review of human papillomavirus prevalence in
1560
3. Muñoz, N., et al. (2004). Against which human papillomavirus types shall we vaccinate
1596
invasive penile cancer. Cancer Causes Control 20(4): 449-457.
1561
and screen? The international perspective. Int J Cancer 111(2): 278-285.
1597
19. Arbyn, M., et al. (2020). Estimates of incidence and mortality of cervical cancer in 2018:
1562
4.
1598
a worldwide analysis. Lancet Glob Health 8(2): e191-e203.
1563
Vaccine 24 Suppl 3: S3/11-25.
1599
https://www.ncbi.nlm.nih.gov/pubmed/31812369
1564
5.
1600
20. Baldur-Felskov, B., et al. (2014). Incidence of cervical lesions in Danish women before
1565
application. Nat Rev Cancer 2(5): 342-350.
1601
and after implementation of a national HPV vaccination program. Cancer Causes Control
1566
6. Bosch, F. X., et al. (2012). Reframing cervical cancer prevention. Expanding the field
1602
25(7): 915-922. https://www.ncbi.nlm.nih.gov/pubmed/24797870
1567
towards prevention of human papillomavirus infections and related diseases. Vaccine 30
1603
21. Gertig, D. M., et al. (2013). Impact of a population-based HPV vaccination program on
1568
Suppl 5: F1-11.
1604
cervical abnormalities: a data linkage study. BMC Med 11: 227.
1569
7. Moscicki, A. B., et al. (2012). Updating the natural history of human papillomavirus and
1605
https://www.ncbi.nlm.nih.gov/pubmed/24148310
1570
anogenital cancers. Vaccine 30 Suppl 5(0 5): F24-33.
1606
22. Kjaer, S. K., et al. (2018). A 12-Year Follow-up on the Long-Term Effectiveness of the
1571
8. Demarco, M., et al. (2020). A study of type-specific HPV natural history and implications
1607
Quadrivalent Human Papillomavirus Vaccine in 4 Nordic Countries. Clin Infect Dis 66(3):
1572
for contemporary cervical cancer screening programs. EClinicalMedicine 22: 100293.
1608
339-345.
1573
9. Castle, P. E., et al. (2006). Human papillomavirus prevalence in women who have and
1609
23. Pollock, K. G., et al. (2014). Reduction of low- and high-grade cervical abnormalities
1574
have not undergone hysterectomies. J Infect Dis 194(12): 1702-1705.
1610
associated with high uptake of the HPV bivalent vaccine in Scotland. Br J Cancer 111(9):
1575
10. Moscicki, A. B., et al. (2004). Regression of low-grade squamous intra-epithelial lesions
1611
1824-1830 https://www.ncbi.nlm.nih.gov/pubmed/25180766
1576
in young women. Lancet 364(9446): 1678-1683.
1612
24.
1577
11. Jacobs, M. V., et al. (2000). Distribution of 37 mucosotropic HPV types in women with
1613
cancers. Int J Cancer 142(10): 2186-2187.
1578
cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types.
1614
https://www.ncbi.nlm.nih.gov/pubmed/29280138
1579
Int J Cancer 87(2): 221-227.
1615
25. Guo, F., et al. (2018). Cervical Cancer Incidence in Young U.S. Females After Human
1580
12. Hildesheim, A., et al. (2007). Effect of human papillomavirus 16/18 L1 viruslike particle
1616
Papillomavirus Vaccine Introduction. Am J Prev Med 55(2): 197-204.
1581
vaccine among young women with preexisting infection: a randomized trial. Jama 298(7):
1617
https://www.ncbi.nlm.nih.gov/pubmed/29859731
1582
743-753.
1618
26. Lei, J., et al. (2020). HPV Vaccination and the Risk of Invasive Cervical Cancer. N Engl
1583
13. Woodman, C. B., et al. (2007). The natural history of cervical HPV infection: unresolved
1619
J Med 383(14): 1340-1348. https://www.ncbi.nlm.nih.gov/pubmed/32997908
1584
issues. Nat Rev Cancer 7(1): 11-22.
1620
27. 国⽴がん研究センター がん情報サービス. がんに関する統計データのダウンロード.
Parkin, D. M. and F. Bray (2006). Chapter 2: The burden of HPV-related cancers.
zur Hausen, H. (2002). Papillomaviruses and cancer: from basic studies to clinical
Luostarinen, T., et al. (2018). Vaccination protects against invasive HPV-associated
1585
14. Matsumoto, K., et al. (2011). Predicting the progression of cervical precursor lesions by
1621
https://ganjoho.jp/reg_stat/statistics/dl/index.html
1586
human papillomavirus genotyping: a prospective cohort study. Int J Cancer 128(12): 2898-
1622
28. Katanoda, K., et al. (2017). Childhood, adolescent and young adult cancer incidence in
1587
2910.
1623
Japan in 2009-2011. Jpn J Clin Oncol 47(8): 762-771.
81
82